1.Study of Teacher's Work Related Stress in the Special Education Field (review)
Chinese Journal of Rehabilitation Theory and Practice 2006;12(12):1083-1085
The author reviewed some researches on teacher's work related stress in China and abroad. The present researches mainly focus on the sources of stress in teachers' work life. Some practices of work related stress in USA and Chinese special education field were discussed in the article. In the end, the author took a perspective on future research of teacher's work related stress in Chinese special education field.
2.Chemical constituents of volatile oil of Viola yedoensis Makino from two habitats
Jia LIU ; Runsheng XU ; Cungui CHENG
Chinese Traditional Patent Medicine 1992;0(10):-
AIM:To analyse the chemical constituents of volatile components from Viola yedoensis Makino. METHODS: The essential oils from Viola yedoensis Makino(collected from Jinhua city and Changchun city) were extracted by steam distillation.The chemical compounds were separated and identified by GC-MS.The relative content of each component was determined by area normalization. RESULTS: Twenty-five and twenty-three constituents were separated from Viola yedoensis Makino collected from Changchun city and Jinhua city;twenty-one and twenty-two compounds were identified respectively.The ratios of identification of total compounds were 88.00% and 91.30% respectively. CONCLUSION: There are significant difference between two varieties of Viola yedoensis Makino,the main coustituents in each plant are n-hexadecanoic acid(16.77%)and phytol(26.97%).
3.Clinical applications of molecular biomarkers in urothelial carcinoma of bladder.
Liang CHENG ; Jia-wen XU ; Jia-jia HE ; Jing ZHAO ; Xiao-dong TENG
Chinese Journal of Pathology 2011;40(10):714-717
Antineoplastic Combined Chemotherapy Protocols
;
therapeutic use
;
Basigin
;
analysis
;
Biomarkers, Tumor
;
analysis
;
genetics
;
Carcinoma, Transitional Cell
;
drug therapy
;
genetics
;
metabolism
;
Gene Expression Profiling
;
Humans
;
In Situ Hybridization, Fluorescence
;
Inhibitor of Apoptosis Proteins
;
analysis
;
Mutation
;
Neoplasm Recurrence, Local
;
metabolism
;
Nuclear Proteins
;
analysis
;
Receptor, Fibroblast Growth Factor, Type 3
;
analysis
;
genetics
;
Tumor Suppressor Protein p53
;
analysis
;
genetics
;
Urinary Bladder Neoplasms
;
drug therapy
;
genetics
;
metabolism
4.Thinking of study on secondary development of major traditional Chinese medicine varieties based on system theory.
Xu-Dong CHENG ; Xiao-Bin JIA ; Liang FENG ; Jun JIANG
China Journal of Chinese Materia Medica 2013;38(24):4369-4374
The secondary development of traditional Chinese medicines (TCMs) is an important content of TCM modernization process, as well as an important path for developing new TCM drugs. Under the guidance of the system theory, in response to the lack of the overall guideline and practical methods for the secondary development of TCMs at present, we introduced the overall thought of the secondary development of major TCM varieties, as well as the roles and contents of clinical research, pharmacology and pharmaceutics in the process of the secondary development of major TCM varieties, so as to provide systematic strategies and methods for the development of major TCM varieties.
Biomedical Research
;
Drug Discovery
;
methods
;
Humans
;
Medicine, Chinese Traditional
;
methods
;
Pharmacology
5.Study thought of material basis of secondary development of major traditional Chinese medicine varieties on basis of combination of in vivo and in vitro experiments.
Xu-Dong CHENG ; Xiao-Bin JIA ; Liang FENG ; Jun JIANG
China Journal of Chinese Materia Medica 2013;38(23):4174-4180
The secondary development of major traditional Chinese medicine varieties is one of important links during the modernization, scientification and standardization of traditional Chinese medicines. How to accurately and effectively identify the pharmacodynamic material basis of original formulae becomes the primary problem in the secondary development, as well as the bottleneck in the modernization development of traditional Chinese medicines. On the basis of the existing experimental methods, and according to the study thought that the multi-component and complex effects of traditional Chinese medicine components need to combine multi-disciplinary methods and technologies, we propose the study thought of the material basis of secondary development of major traditional Chinese medicine varieties based on the combination of in vivo and in vitro experiments. It is believed that studies on material basis needs three links, namely identification, screening and verification, and in vivo and in vitro study method corresponding to each link is mutually complemented and verified. Finally, the accurate and reliable material basis is selected. This thought provides reference for the secondary development of major traditional Chinese medicine varieties and studies on compound material basis.
Absorption
;
Animals
;
Drug Discovery
;
methods
;
Humans
;
Medicine, Chinese Traditional
;
methods
6.The protection of selenium-tea in Enshi on the damage of hypoxia/reoxygenation in mice and the influence of ketamine on it.
Cheng-Fu YUAN ; Zhi-Xin TAN ; Jia-Nan XU
Chinese Journal of Applied Physiology 2003;19(4):317-362
Animals
;
Female
;
Hypoxia
;
prevention & control
;
Ketamine
;
pharmacology
;
Male
;
Mice
;
Mice, Inbred Strains
;
Selenium
;
pharmacology
;
Tea
7.Are Chinese medical journals far from digital publishing?
Zhuming JIANG ; Yuhua CHENG ; Xiaowei JIA ; Ting LEI ; Yuxia XU
Chinese Journal of Clinical Nutrition 2011;19(5):285-287
Many medical journals have already digitalized their publishing procedure,but not achieved digital publishing yet.Utilizing digital technology,digital publishing can achieve the functions that paper media cannot,such as information storage,fast search,real-time publishing,individualized information and interaction with readers.These functions entail digitalization of medical journals,and involve a range of macro- and micro-modifications,including laws,industry policies,personnel training,and culture development.There is a long way to go for Chinese medical journals to enter the stage of digital publishing.
8.Progresses and analysis in fibrinolytic drugs induced hemorrhage
Ming-qing TANG ; Cheng-jia HU ; Rui-an XU
Acta Pharmaceutica Sinica 2023;58(6):1521-1527
At present, most clinical thrombolytic drugs are plasminogen activators, which are highly dependent on the plasminogen level of the patient. Therefore, the efficacy of those drugs is restricted. Unlike the conventional thrombolytic plasminogen activator drugs, fibrinolytic drugs have direct fibrinolytic activity. Thus, fibrinolytic drugs can directly dissolve the thrombus, and its thromlysis efficacy is not restricted by the patients' plasminogen. This is a new type of thrombolytic drug with higher thrombolytic efficiency and safety, and has become one of the research hotspots at present. Although more and more agents that can be used as fibrinolytic drugs have been discovered, only a few of them can successfully be applied in clinical practice. The mainly underlying reason is the risk of bleeding. In this paper, based on the latest research progress of fibrinolytic drugs, the bleeding mechanisms and coping strategies of fibrinolytic drugs were systematically reviewed, five types of bleeding mechanisms of fibrinolytic drugs were summarized, and three types of coping strategies were proposed. We hope our work can provide theoretical basis for the development of safer and more efficient fibrinolytic drugs.
9.Recent advances in diagnosis of flat lesions of urinary bladder.
Liang CHENG ; Jia-wen XU ; Xiao-Dong TENG
Chinese Journal of Pathology 2010;39(9):577-581
Antigens, CD20
;
metabolism
;
Carcinoma in Situ
;
classification
;
diagnosis
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Humans
;
Hyaluronan Receptors
;
metabolism
;
Hyperplasia
;
Precancerous Conditions
;
diagnosis
;
metabolism
;
pathology
;
Tumor Suppressor Protein p53
;
metabolism
;
Urinary Bladder
;
metabolism
;
pathology
;
Urinary Bladder Neoplasms
;
classification
;
diagnosis
;
metabolism
;
pathology
;
Urothelium
;
metabolism
;
pathology
10.Clinical efficacy of anatomic liver resection in the treatment of hepatocellular carcinoma with microvascular invasion
Ya CHENG ; Weidong JIA ; Songge XING ; Geliang XU
Chinese Journal of Digestive Surgery 2017;16(2):144-150
Objective To explore the clinical efficacy of anatomic liver resection in treatment of hepatocellular carcinoma (HCC) with microvascular invasion (MVI).Methods The retrospective cohort and case-control study was conducted.The clinical data of 150 HCC patients with MVI who were admitted to the Anhui Medical University Affiliated Provincial Hospital from June 2007 to June 2012 were collected.Sixty patients undergoing anatomic liver resection were allocated into the AR group and 90 undergoing non-anatomic liver resection in the NR group.Patients in the AR group underwent anatomic liver resection according to results of preoperative ICG R15 test,and patients in the NR group underwent non-anatomic liver resection.Observation indicators:(1) operation situations:operation time,volume of intraoperative blood loss,number of patients with blood transfusion;(2) postoperative recovery situations:time of drainage-tube removal,duration of hospital stay,Clavein grade of complication within 30 days postoperatively,number of patients with hepatic failure within 30 days postoperatively and number of death within 30 days postoperatively;(3) follow-up:postoperative median survival time,5-year overall survival rate and 5-year tumor-free survival rate;(4) prognostic factors analysis of 150 HCC patients with MVI.Measurement data with normal distribution were represented as-x±s and comparison between groups was analyzed using the independent-sample t test.Count data were represented as the chi-square test or Fisher exact probability.The survival rate was calculated using the Kaplan-Meier method and survival analysis was done using Log-rank test.The univariate analysis and multivariate analysis were done using the COX regression model.Results (1) Operation situations:all the 150 patients received successful radical resection of HCC.Operation time,numbers of patients with volume of intraoperative blood loss ≥ 500 mL and with volume of intraoperative blood loss < 500 mL and number of patients with blood transfusion were (165±39) minutes,12,48,15 in the AR group and (136±30)minutes,34,56,38 in the NR group,respectively,with statistically significant differences between the 2 groups (t =29.172,x2=5.351,4.673,P<0.05).(2) Postoperative recovery situations:time of drainage-tube removal and duration of hospital stay were (2.7± 1.1)days and (5.2± 1.3) days in the AR group,(3.8±1.6)days and (7.1±2.3)days in the NR group,respectively,with statistically significant differences between the 2 groups (t =4.641,5.812,P<0.05).Numbers of patients with grade Ⅰ-Ⅱ of Clavein grade and with grade Ⅲ-Ⅳ and number of death within 30 days postoperatively were 45,15,1 in the AR group and 61,29,2 in the NR group,respectively,with no statistically significant difference between the 2 groups (x2 =0.906,P>0.05).Number of patients with hepatic failure within 30 days postoperatively in the AR and NR group were respectively 4 and 17,with a statistically significant difference (x2=4.467,P<0.05).(3) Follow-up:all the 150 patients were followed up for 1-106 months,with a median time of 26 months.The postoperative median survival time,5-year overall survival rate and 5-year tumor-free survival rate were 46 months,33.3%,21.7% in the AR group and 18 months,15.6%,2.2% in the NR group,respectively,with statistically significant differences in overall survival and tumor-free survival between the 2 groups (x2=23.718,63.932,P< 0.05).(4) Prognostic factors analysis of 150 HCC patients with MVI:result of univariate analysis showed that maximum diameter of tumor,tumor capsule,TNM stage,Edmondson grade and surgical procedures were relative factors affecting overall survival and tumor-free survival of HCC patients with MVI,with statistically significant differences (x2=5.519,2.790,13.639,8.321,42.470,31.057,15.963,19.594,23.718,63.932,P< 0.05).Result of multivariate analysis showed that missing tumor capsule,stage Ⅲ-Ⅳ of TNM stage,grade Ⅲ-Ⅳ of Edmondson grade and non-anatomic liver resection were independent factors affecting poor overall survival and tumor-free survival of HCC patients with MVI,and maximum diameter of tumor >5 cm was an independent factor affecting poor overall survival of HCC patients with MVI,with a statistically significant difference [HR =0.527,0.683,0.333,0.522,0.576,0.514,0.523,0.268,95% confidence interval (CI):0.355-0.782,0.475-0.983,0.219-0.504,0.361-0.755,0.389-0.852,0.358-0.737,0.342-0.800,0.174-0.413;HR=0.559,95%CI:0.370-0.845,P<0.05].Conclusions Anatomic liver resection in the treatment of HCC patients with MVI is safe and effective,with good short-term and long-term outcomes,and it can also improve prognosis of patients.Missing tumor capsule,stage Ⅲ-Ⅳ of TNM stage,grade Ⅲ-Ⅳ of Edmondson grade and non-anatomic liver resection are independent factors affecting poor overall survival and tumor-free survival of HCC patients with MVI,and maximum diameter of tumor >5 cm is an independent factor affecting poor overall survival of HCC patients with MVI.